TScan Therapeutics (TCRX) Enterprise Value: 5.011M

TScan Therapeutics, Inc. (TCRX)

0.2377 +0.03 (+12.87%) USD | NASDAQ | Oct 15, 16:00

0.2377 0.00 (0.00%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2021. Start Trial.

Date	Value
October 14, 2026	5.011M
October 13, 2026	5.425M
October 12, 2026	6.862M
October 09, 2026	6.868M
October 08, 2026	6.204M
October 07, 2026	9.505M
October 06, 2026	9.403M
October 05, 2026	10.75M
October 02, 2026	12.46M
October 01, 2026	12.26M
September 30, 2026	12.05M
September 29, 2026	12.26M
September 28, 2026	13.78M
September 25, 2026	13.78M
September 24, 2026	14.39M
September 23, 2026	15.41M
September 22, 2026	14.79M
September 21, 2026	13.14M
September 18, 2026	11.88M
September 17, 2026	13.34M
September 16, 2026	13.17M
September 15, 2026	12.51M
September 14, 2026	11.50M
September 11, 2026	12.45M
September 10, 2026	12.28M

Date	Value
September 09, 2026	13.11M
September 08, 2026	14.11M
September 04, 2026	17.27M
September 03, 2026	15.88M
September 02, 2026	16.57M
September 01, 2026	35.90M
August 31, 2026	40.20M
August 28, 2026	41.81M
August 27, 2026	41.58M
August 26, 2026	43.43M
August 25, 2026	44.53M
August 24, 2026	44.91M
August 21, 2026	43.57M
August 20, 2026	43.35M
August 19, 2026	41.57M
August 18, 2026	46.63M
August 17, 2026	43.84M
August 14, 2026	43.52M
August 13, 2026	43.06M
August 12, 2026	43.13M
August 11, 2026	43.39M
August 10, 2026	42.72M
August 07, 2026	44.70M
August 06, 2026	42.47M
August 05, 2026	43.60M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks